Linked Life Data

6352637

Source:http://linkedlifedata.com/resource/pubmed/id/6352637

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1983-11-23
pubmed:abstractText
Twelve adults and children with cystic fibrosis received a total of 17 courses of ceftazidime for the treatment of an acute exacerbation of respiratory tract infection. In 6 cases ceftazidime was given as the sole antibiotic. All patients who were clinically assessable were considered to be cured of the acute infection, or improved. Bacteriologically all initial sputum specimens contained Pseudomonas aeruginosa. In 13 instances the organism disappeared during treatment, while in the other 4 the organism remained although the patients improved clinically. Additional organisms, usually Staphylococcus aureus or Haemophilus influenzae, were present in 7 instances. One patient suffered from nausea, palpitations and local skin inflammation on injection whilst being treated with ceftazidime, but the relationship between these adverse effects and ceftazidime was uncertain. The patient tolerated these effects without discontinuation of the drug.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0305-7453
pubmed:author
pubmed:issnType
Print
pubmed:volume
12 Suppl A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
325-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1983
pubmed:articleTitle
Experience with ceftazidime in cystic fibrosis.
pubmed:publicationType
Journal Article